aod9604 phase 2 trial results weight loss AOD 9604 with tirzepatide: the complete combination guide for enhanced fat ๐จ 70 pounds. That's the
70 pounds. That's the average weight loss adults with obesity saw on the highest dose of an investigational once weekly Lilly medicine in a new Phase 3 study over 18 months. Nearly AOD 9604 Clinical Trial Results & FDA Status (2026) AOD 9604 Peptide USA Made High Purity Research Grade AOD 9604 vs Semaglutide: 0% vs 15% Fat Loss (2026 Data) Prost Biotech Retatrutide + AOD 9604 Stack: Fat Loss Protocol Guide
Pay in 4 interest-free payments of $7.46 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours ยท Estimated delivery Aug 3 - Aug 8


